CG Oncology (CGON) Stock Forecast & Price Target
Score
CG Oncology Inc. price target
| CGON | |
|---|---|
| Low | $80.00 |
| Average | $86.50 |
| High | $100.00 |
| Upside vs current price | +2.0% |
The average target of $86.50 is +2.0% versus the current CGON price of $84.78.
CG Oncology Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 4 |
| Buy | 10 |
| Hold | 1 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
15 analysts cover CGON.
CG Oncology Inc. EPS and revenue estimates
The estimate table for the CG Oncology Inc. keeps 2026 EPS $-3.32, 2027 EPS $-3.13, and years with fewer than three analysts are not filled in.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $-3.32 | $4.34M |
| 2027 | $-3.13 | $80.64M |
Is CG Oncology Inc. a buy or sell?
Of the 15 analysts covering CG Oncology Inc., 14 rate it a buy (4 strong buy and 10 buy), 1 rates it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The CGON consensus label is Buy, beside 14 buy-side ratings and 0 sell-side ratings.
The average target of $86.50 implies +2.0% versus the current price of $84.78.
the CG Oncology Inc. closes with 14 buy-side ratings and 0 on the sell side. The headcount is Buy.
Reading the CG Oncology Inc. forecast
Between the CGON low of $80.00 and the high of $100.00, the average target is $86.50.
From today's $84.78 print, the CGON average target is +2.0% away.
Most of the CGON coverage agrees: 14 of 15 analysts are on the buy side, 1 is at hold, and 0 are on the sell side, and the published consensus is Buy.
Earnings estimates for CGON are rising: 2026 $-3.32, then 2027 $-3.13.
Coverage of CGON is broad at 15 analysts, and the average is a crowd rather than a single desk.
CG Oncology Inc. forecast questions
What is the CGON price target?
The published range for CGON is $80.00 to $100.00, with an average of $86.50. That average is +2.0% versus the current price of $84.78.
Is CG Oncology Inc. a buy or sell?
Of the 15 analysts covering CG Oncology Inc., 14 rate it a buy, 1 rates it a hold, and 0 rate it a sell. The consensus is Buy, which for CGON is 14 on the buy side, 1 at hold, and 0 on the sell side.
What is the EPS estimate for CG Oncology Inc.?
Analyst EPS estimates for CG Oncology Inc.: 2026 $-3.32, 2027 $-3.13.
What is the revenue estimate for CG Oncology Inc.?
Analyst revenue estimates for CG Oncology Inc.: 2026 $4.34M, 2027 $80.64M.
How many analysts cover CGON?
15 analysts cover CGON. Their consensus on CGON is Buy, across those 15.